
Infasurf Market Report 2026
Epidemiology, Pipeline Analysis, Market Insights & Forecasts
Infasurf Market Overview
• The Infasurf market growth in the historic period has been driven by high incidence of neonatal respiratory distress syndrome, proven efficacy of surfactant replacement • Market expansion is supported by rising global preterm births, growth in neonatal healthcare spending • Growth Driver: Rising Prevalence Of Premature Births Expected To Boost Demand For Infasurf Amid Health Complications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Infasurf Market?
Infasurf is a natural surfactant primarily used in the treatment of respiratory distress syndrome in premature infants. It is a lung surfactant derived from bovine lungs and contains phospholipids, including dipalmitoyl phosphatidylcholine, which help lower surface tension in the lungs, improving gas exchange. The main patient demographics of infasurf are premature infants, full-term infants, and age groups. Premature infants are babies born before 37 weeks of gestation, often with underdeveloped organs, particularly the lungs. Infasurf is used in premature infants to prevent or treat respiratory distress syndrome by enhancing lung surfactant levels. It is distributed through various channels such as hospitals, specialty clinics, online pharmacies, and pharmacies, and several applications include neonatal respiratory distress syndrome and other respiratory conditions.
What Is The Infasurf Market Size and Share 2026?
The growth in the historic period can be attributed to high incidence of neonatal respiratory distress syndrome, proven efficacy of surfactant replacement, expansion of nicu facilities, increased survival of premature infants, hospital adoption of surfactant therapy.What Is The Infasurf Market Growth Forecast?
The growth in the forecast period can be attributed to rising global preterm births, growth in neonatal healthcare spending, improved access to nicu care, advances in surfactant formulation, expanding neonatal care infrastructure. Major trends in the forecast period include rising use of natural lung surfactants, growth in preterm birth rates, improved neonatal intensive care protocols, early intervention for respiratory distress, standardization of neonatal surfactant therapy.Global Infasurf Market Segmentation
1) By Patient Demographics: Premature Infants, Full-Term Infants, Age Groups 2) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies, Pharmacies 3) By Application: Neonatal Respiratory Distress Syndrome, Other Respiratory ConditionsWhat Are The Drivers Of The Infasurf Market?
The rising prevalence of premature births is expected to drive the expansion of the infasurf market in the coming years. Premature birth, also known as preterm birth, is defined as the birth of a baby before 37 weeks of gestation, in contrast to a full-term delivery, which typically occurs around 40 weeks, and it can lead to various health complications for the infant, including respiratory issues, developmental delays, and an increased risk of long-term disabilities. The rising prevalence of premature births can be attributed to various factors, including rising maternal age, higher rates of multiple pregnancies due to assisted reproductive technologies, and the impact of chronic health conditions and infections during pregnancy. Infasurf (calfactant) is administered directly into the lungs of premature infants to prevent or treat respiratory distress syndrome (RDS) by reducing surface tension and improving lung function. For instance, in October 2024, according to a report published by the University of Bristol, a UK-based public research university, about one in 13 births is preterm, totaling over 50,000 cases annually. Despite preventive measures for high-risk women, preterm birth rates continue to rise. Therefore, the rising prevalence of premature births is contributing to the growth of the infasurf industry. Increasing healthcare spending is expected to propel the growth of the infasurf market going forward. Healthcare spending refers to the total financial resources allocated by individuals, governments, private insurers, and other entities towards the provision of healthcare services and products. The rise in healthcare spending is attributed to an aging population, advancements in medical technology, rising prevalence of chronic diseases, and increased demand for healthcare services. Infasurf is beneficial for healthcare spending by minimizing the financial burden associated with extended hospital stays and complex respiratory interventions for premature infants with respiratory distress syndrome, ultimately optimizing cost-effectiveness in neonatal care. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure in the UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, the rising healthcare expenditure is driving the growth of the infasurf industry. Rising awareness of infant respiratory disorders is expected to propel the growth of the infasurf market going forward. Infant respiratory disorders refer to a range of conditions that affect the breathing and lung function of newborns, often resulting from underdeveloped lungs or complications during birth. The increasing prevalence of infant respiratory disorders is driven by rising premature birth rates, maternal health complications, environmental factors, higher cesarean delivery rates, and improved detection and diagnosis through advanced medical technologies. Infasurf, a surfactant replacement therapy, helps treat infant respiratory disorders by improving lung function and oxygenation in premature infants with respiratory distress syndrome, reducing the surface tension in the lungs and enhancing their ability to expand and exchange gases effectively. For instance, in September 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, an estimated 58,000 to 80,000 children under the age of 5 are hospitalized annually in the United States due to RSV infection, with infants being at the highest risk. Therefore, the rising awareness of infant respiratory disorders is driving the growth of the infasurf industry.Key Players In The Global Infasurf Market
Major companies operating in the infasurf market are ONY Biotech Inc.Regional Insights
North America was the largest region in the infasurf market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.What Defines the Infasurf Market?
The infasurf market consists of sales of infasurf 3 ml intratracheal suspension. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Infasurf Market Report 2026?
The infasurf market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the infasurf industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Infasurf Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $ billion |
| Revenue Forecast In 2035 | $ billion |
| Growth Rate | No CAGR found from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Patient Demographics, Distribution Channel, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | ONY Biotech Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
